Soft-tissue sarcoma in adolescents and young adults

被引:0
|
作者
Toshiyuki Kunisada
Eiji Nakata
Tomohiro Fujiwara
Ako Hosono
Shota Takihira
Hiroya Kondo
Toshifumi Ozaki
机构
[1] Okayama University Graduate School of Medicine,Department of Orthopaedic Surgery
[2] Dentistry,Department of Medical Materials for Musculoskeletal Reconstruction
[3] and Pharmaceutical Sciences,Department of Pediatric Oncology
[4] Okayama University Graduate School of Medicine,undefined
[5] Dentistry,undefined
[6] and Pharmaceutical Sciences,undefined
[7] National Cancer Center Hospital East,undefined
来源
International Journal of Clinical Oncology | 2023年 / 28卷
关键词
Sarcoma; Soft tissue; Adolescents and young adults;
D O I
暂无
中图分类号
学科分类号
摘要
Soft-tissue sarcoma is a rare cancer that accounts for approximately 1% of all malignant tumors. Although they occur in various age groups, soft-tissue sarcomas account for 8% of all malignant tumors developing in adolescents and young adults, suggesting that they are not rare in this age group. This study aimed to evaluate the clinical and pathological characteristics of soft-tissue sarcoma in adolescents and young adults. According to the Bone and Soft-Tissue Tumor Registry in Japan, myxoid liposarcoma is the most common type of soft-tissue sarcoma found in adolescents and young adults; alveolar soft part sarcoma, extraskeletal Ewing sarcoma, epithelioid sarcoma, clear cell sarcoma and synovial sarcoma occur predominantly in this age group among soft-tissue sarcomas. The analysis based on this registry demonstrated that age was not a prognostic factor for poor survival of soft-tissue sarcoma, although the prognosis in adolescents and young adults was better than that in older patients in the US and Scandinavia. Adolescent and young adult patients with soft-tissue sarcoma have age-specific problems, and a multidisciplinary approach to physical, psychological, and social issues is necessary to improve the management of these young patients both during and after treatment.
引用
收藏
页码:1 / 11
页数:10
相关论文
共 50 条
  • [41] SOFT-TISSUE SARCOMA IN MAN - EVIDENCE FOR INFECTIVE OR ENVIRONMENTAL ETIOLOGY
    DARBY, CR
    GREENALL, MJ
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1991, 17 (02): : 225 - 226
  • [42] Soft-Tissue Lesions: When Can We Exclude Sarcoma?
    Chhabra, Avneesh
    Soldatos, Theodoros
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 199 (06) : 1345 - 1357
  • [43] Adjuvant epirubicin with or without ifosfamide for adult soft-tissue sarcoma
    Petrioli, R
    Coratti, A
    Correale, P
    D'Aniello, C
    Grimaldi, L
    Tanzini, G
    Civitelli, S
    Marsili, S
    Messinese, S
    Marzocca, G
    Pirtoli, L
    Francini, G
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (05): : 468 - 473
  • [44] Osseous invasion by soft-tissue sarcoma: Assessment with MR imaging
    Elias, DA
    White, LM
    Simpson, DJ
    Kandel, RA
    Tomlinson, G
    Bell, RS
    Wunder, JS
    RADIOLOGY, 2003, 229 (01) : 145 - 152
  • [45] Clinical presentation, treatment, and outcome of alveolar soft part sarcoma in children, adolescents, and young adults
    Kayton, ML
    Meyers, P
    Wexler, LH
    Gerald, WL
    LaQuaglia, MP
    JOURNAL OF PEDIATRIC SURGERY, 2006, 41 (01) : 187 - 193
  • [46] LONG-TERM SURVIVAL IN HIGH-GRADE SOFT-TISSUE SARCOMA - PROGNOSTIC FACTORS IN SYNOVIAL SARCOMA
    CHOONG, PFM
    PRITCHARD, DJ
    SIM, FH
    ROCK, MG
    NASCIMENTO, AG
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 7 (01) : 161 - 169
  • [47] Soft-tissue sarcomas: an update
    Somerhausen, ND
    Fletcher, CDM
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1999, 25 (02): : 215 - 220
  • [48] Insurance impacts survival for children, adolescents, and young adults with bone and soft tissue sarcomas
    Penumarthy, Neela L.
    Goldsby, Robert E.
    Shiboski, Stephen C.
    Wustrack, Rosanna
    Murphy, Patricia
    Winestone, Lena E.
    CANCER MEDICINE, 2020, 9 (03): : 951 - 958
  • [49] Clinical trial enrollment of adolescents and young adults with sarcoma
    Davis, Lara E.
    Janeway, Katherine A.
    Weiss, Aaron R.
    Chen, Yen-Lin E.
    Scharschmidt, Thomas J.
    Krailo, Mark
    Bender, Julia L. Glade
    Kopp, Lisa M.
    Patel, Shreyaskumar R.
    Schwartz, Gary K.
    Horvath, L. Elise
    Hawkins, Douglas S.
    Chuk, Meredith K.
    Reinke, Denise K.
    Gorlick, Richard G.
    Randall, R. Lor
    CANCER, 2017, 123 (18) : 3434 - 3440
  • [50] Ridaforolimus: a promising drug in the treatment of soft-tissue sarcoma and other malignancies
    Dancey, Janet E.
    Monzon, Jose
    FUTURE ONCOLOGY, 2011, 7 (07) : 827 - 839